Gold L H, Stinus L, Inturrisi C E, Koob G F
Department of Neuropharmacology, Scripps Research Institute, La Jolla, CA 92037.
Eur J Pharmacol. 1994 Feb 21;253(1-2):45-51. doi: 10.1016/0014-2999(94)90755-2.
Opiate withdrawal is a common occurrence in human opiate addicts that is no life threatening but is hypothesized to be a significant factor which may contribute to drug taking behavior in these opiate dependent individuals. The purpose of this study was to compare the time course for the development of tolerance, dependence and abstinence using a rat model. Rats were made dependent by implantation of 2 morphine pellets s.c. (75 mg morphine base). Morphine implanted rats exhibited analgesia as measured in a tail-dip assay, for up to 12 h post-implant after which the development of tolerance resulted in tail-flick latencies returning to the level of control rats. Withdrawal was evaluated by injection of the opiate antagonist, naloxone (1 mg/kg s.c.). Rating of the abstinence syndrome revealed significant withdrawal signs by 3 h post-implant which became increasingly intense up to 24 h post-implant. Withdrawal could be precipitated for at least 13 days post-implant, while by 18 days post-implant almost no abstinence signs were observed. Plasma morphine levels following implantation of 2 pellets remained relatively stable from 3-12 days post-implantation. These results further extend the characterization of opiate abstinence following subcutaneous pellet implantation. These results also suggest that opiate abstinence develops within the first 24 h and follows the time course of the development of tolerance. The characterization of the evolution of opiate tolerance, physical dependence and abstinence under similar experimental conditions is critical to the design of future studies to examine the neural bases for these phenomena.
阿片类药物戒断在人类阿片类药物成瘾者中很常见,虽无生命危险,但据推测是导致这些阿片类药物依赖个体出现吸毒行为的一个重要因素。本研究的目的是使用大鼠模型比较耐受性、依赖性和戒断反应发展的时间进程。通过皮下植入2粒吗啡丸(75mg吗啡碱)使大鼠产生依赖性。植入吗啡的大鼠在尾浸试验中表现出镇痛作用,植入后长达12小时,之后耐受性的发展导致甩尾潜伏期恢复到对照大鼠的水平。通过注射阿片类拮抗剂纳洛酮(1mg/kg皮下注射)来评估戒断反应。戒断综合征评分显示,植入后3小时出现明显的戒断症状,直至植入后24小时症状愈发严重。植入后至少13天可引发戒断反应,而植入后18天时几乎未观察到戒断症状。植入2粒药丸后,血浆吗啡水平在植入后3至12天保持相对稳定。这些结果进一步扩展了皮下植入药丸后阿片类药物戒断的特征描述。这些结果还表明,阿片类药物戒断在最初24小时内出现,并遵循耐受性发展的时间进程。在相似实验条件下对阿片类药物耐受性、身体依赖性和戒断反应演变的特征描述,对于未来研究这些现象的神经基础的设计至关重要。